scPharmaceuticals Inc.
SCPHDelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001604950
scPharmaceuticals Inc. was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 7, 2025; 110 institutions reported holding it in 13F filings for Q3 2025, worth $232.3M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding scPharmaceuticals Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 37 | 38 | +1 |
| Shares | 15.9M | 15.7M | −187.7K (−1.2%) |
| Value | $90.1M | $75.9M | −$14.2M (−15.7%) |
New holders (4)
Institutions that held scPharmaceuticals Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 2,700,000 | $13.0M | 0.33% |
| Commonwealth Equity Services, LLC | 15,530 | $74.0K | 0.00% |
| Wolverine Trading, LLC | 13,770 | $68.0K | 0.00% |
| Virtu Financial LLC | 10,999 | $53.0K | 0.00% |
Sold out (3)
Institutions that held scPharmaceuticals Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Ra Capital Management, L.P. | 2,658,583 | $15.1M |
| J. Goldman & Co LP | 67,500 | $383.0K |
| Envestnet Asset Management Inc | 10,228 | $58.0K |